Resources Contact Us Home
CA IX-specific inhibitors

Image Number 6 for United States Patent #7550424.

Therapeutic methods for inhibiting the growth of preneoplastic/neoplastic vertebrate cells that abnormally express MN protein are disclosed. Screening assays are provided for identifying compounds, preferably membrane-impermeant compounds, which inhibit the enzymatic activity of MN protein/polypeptides and that are useful for treating patients with preneoplastic/neoplastic disease. Further methods are disclosed for the preparation of positively-charged, membrane-impermeant heterocyclic sulfonamide CA inhibitors with high affinity for the membrane-bound carbonic anhydrase CA IX. Preferred CA IX-specific inhibitors are aromatic and heterocylic sulfonamides, preferably that are membrane-impermeant. Particularly preferred CA IX-specific inhibitors are pyridinium derivatives of such aromatic and heterocyclic sulfonamides. The CA IX-specific inhibitors of the invention can also be used diagnostically/prognostically for preneoplastic/neoplastic disease, and for imaging use, for example, to detect precancerous cells, tumors and/or metastases. The CA IX-specific inhibitors can be labelled or conjugated to radioisotopes for radiotherapy. The CA IX-specific inhibitors may be combined with conventional therapeutic anti-cancer drugs, with other different inhibitors of cancer-related pathways, with bioreductive drugs, or with radiotherapy to enhance the efficiency of each treatment. The CA IX-specific inhibitors may also be combined with CA IX-specific antibodies, preferably monoclonal antibodies or biologically active antibody fragments, more preferably humanized or fully human CA IX monoclonal antibodies or biologically active fragments or such monoclonal antibodies. Still further, the CA IX-specific inhibitors can be used for gene therapy coupled to vectors for targeted delivery to preneoplastic/neoplastic cells expressing CA IX on their surfaces.

  Recently Added Patents
Lubricant coating device and image forming apparatus
Lithographic apparatus and device manufacturing method
Solar power system with communication network utilizing magnetic fields
Method and system for simulating wireless networks
Compounds for the reduction of .beta.-amyloid production
Intralevel conductive light shield
Methods and systems for detecting icing conditions
  Randomly Featured Patents
Dental compositions of improved properties
Main mouth of brick molding machine
Control apparatus and control method of a vehicle
Network media access controller embedded in a programmable logic device--statistics interface
(Pyrido/thieno)--[f]--oxazepine-5-one derivatives
2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
Rolling exercise device set
Portable holder and organizer for jewelry and accessories
Method for controlling manufacturing processes via efficient experimental
Adjustable weight lifting holding device for leg lifting exercises